- Title
- Health Insurance - Insulin - Prohibition on Step Therapy or Fail-First Protocols
- Sponsored by
- Delegates Woods, Alston, Bagnall, Bhandari, Chisholm, Davis, Fisher, Ghrist, Guzzone, Harris, Harrison, Kaufman, Kerr, J. Long, Lopez, Martinez, McCaskill, M. Morgan, Patterson, Roberts, Rosenberg, Schmidt, Simmons, Szeliga, Taveras, Taylor, Terrasa, Wilkins, Cullison, Hill, Hutchinson, S. Johnson, Kaiser, Kipke, Pena-Melnyk, Reilly, Ross, White Holland, and Woorman
- Status
- In the Senate - Favorable with Amendments Report by Finance
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from imposing a step therapy or fail-first protocol for insulin used to treat an insured's or enrollee's Type 1, Type 2, or gestational diabetes; and applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2026.
Committees
- Opposite:
- Finance
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
Last Updated: 3/28/2025 3:49 PM
MyMGA
Accessibility Tools